Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A0A3Q8IC17
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0140575 | transmembrane monodehydroascorbate reductase activity | 3 | 10 |
GO:0005488 | binding | 1 | 1 |
GO:0020037 | heme binding | 4 | 1 |
GO:0046906 | tetrapyrrole binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.371 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.557 |
CLV_PCSK_PC1ET2_1 | 106 | 108 | PF00082 | 0.371 |
CLV_PCSK_PC7_1 | 20 | 26 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.388 |
DOC_CYCLIN_yCln2_LP_2 | 99 | 105 | PF00134 | 0.418 |
DOC_PP1_SILK_1 | 93 | 98 | PF00149 | 0.396 |
DOC_PP2B_LxvP_1 | 99 | 102 | PF13499 | 0.418 |
DOC_PP4_MxPP_1 | 142 | 145 | PF00568 | 0.329 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.754 |
LIG_14-3-3_CanoR_1 | 111 | 121 | PF00244 | 0.399 |
LIG_Actin_WH2_2 | 6 | 22 | PF00022 | 0.694 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.398 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.429 |
LIG_LIR_Gen_1 | 60 | 69 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 60 | 64 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 80 | 84 | PF02991 | 0.155 |
LIG_LYPXL_yS_3 | 68 | 71 | PF13949 | 0.327 |
LIG_MYND_2 | 144 | 148 | PF01753 | 0.249 |
LIG_NRBOX | 95 | 101 | PF00104 | 0.334 |
LIG_SH2_CRK | 61 | 65 | PF00017 | 0.353 |
LIG_SH2_STAP1 | 138 | 142 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.589 |
LIG_SH3_2 | 102 | 107 | PF14604 | 0.589 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.564 |
LIG_SUMO_SIM_par_1 | 118 | 124 | PF11976 | 0.380 |
LIG_TRFH_1 | 98 | 102 | PF08558 | 0.561 |
LIG_TYR_ITIM | 59 | 64 | PF00017 | 0.389 |
LIG_WRC_WIRS_1 | 43 | 48 | PF05994 | 0.483 |
LIG_WRC_WIRS_1 | 78 | 83 | PF05994 | 0.405 |
LIG_WW_3 | 31 | 35 | PF00397 | 0.541 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.177 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.218 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.668 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.330 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.423 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.389 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.301 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.391 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.531 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.318 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.536 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.349 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.382 |
MOD_Plk_4 | 91 | 97 | PF00069 | 0.315 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.749 |
MOD_SUMO_rev_2 | 11 | 19 | PF00179 | 0.660 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.365 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.343 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNM4 | Bodo saltans | 26% | 70% |
A0A1X0P2F3 | Trypanosomatidae | 23% | 67% |
A0A3R7RSY6 | Trypanosoma rangeli | 28% | 69% |
A4HID6 | Leishmania braziliensis | 64% | 100% |
A4I5N2 | Leishmania infantum | 99% | 100% |
E9B0X7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4Q789 | Leishmania major | 89% | 100% |
V5BPF8 | Trypanosoma cruzi | 24% | 69% |